USA Cancer Immunotherapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Cancer Immunotherapy market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Cancer Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Cancer Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Novartis International Ag

    • Pfizer Inc

    • Amgen Inc

    • Bristol-Myers Squibb

    • Printegra

    • Celgene Corporation

    • LLC

    • Janssen Global Services

    • Seattle Genetics Inc

    • Merck & Co Inc

    • Gristone Oncology, Inc

    By Type:

    • Monoclonal Antibodies

    • Immune Checkpoint Inhibitors

    • Immune System Modulators

    • Cancer Vaccines

    By End-User:

    • Lung Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Melanoma

    • Prostate Cancer

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Immunotherapy Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Cancer Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

      • 1.3.2 USA Cancer Immunotherapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027

      • 1.3.3 USA Cancer Immunotherapy Market Size and Growth Rate of Immune System Modulators from 2016 to 2027

      • 1.3.4 USA Cancer Immunotherapy Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Cancer Immunotherapy Market Size and Growth Rate of Lung Cancer from 2016 to 2027

      • 1.4.2 USA Cancer Immunotherapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027

      • 1.4.3 USA Cancer Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027

      • 1.4.4 USA Cancer Immunotherapy Market Size and Growth Rate of Melanoma from 2016 to 2027

      • 1.4.5 USA Cancer Immunotherapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

      • 1.4.6 USA Cancer Immunotherapy Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Cancer Immunotherapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer Immunotherapy by Major Types

      • 3.4.1 Market Size and Growth Rate of Monoclonal Antibodies

      • 3.4.2 Market Size and Growth Rate of Immune Checkpoint Inhibitors

      • 3.4.3 Market Size and Growth Rate of Immune System Modulators

      • 3.4.4 Market Size and Growth Rate of Cancer Vaccines

    4 Segmentation of Cancer Immunotherapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer Immunotherapy by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Cancer Immunotherapy in Lung Cancer

      • 4.4.2 Market Size and Growth Rate of Cancer Immunotherapy in Breast Cancer

      • 4.4.3 Market Size and Growth Rate of Cancer Immunotherapy in Colorectal Cancer

      • 4.4.4 Market Size and Growth Rate of Cancer Immunotherapy in Melanoma

      • 4.4.5 Market Size and Growth Rate of Cancer Immunotherapy in Prostate Cancer

      • 4.4.6 Market Size and Growth Rate of Cancer Immunotherapy in Others

    5 Market Analysis by Regions

    • 5.1 USA Cancer Immunotherapy Production Analysis by Regions

    • 5.2 USA Cancer Immunotherapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Cancer Immunotherapy Landscape Analysis

    • 6.1 West USA Cancer Immunotherapy Landscape Analysis by Major Types

    • 6.2 West USA Cancer Immunotherapy Landscape Analysis by Major End-Users

    7 South USA Cancer Immunotherapy Landscape Analysis

    • 7.1 South USA Cancer Immunotherapy Landscape Analysis by Major Types

    • 7.2 South USA Cancer Immunotherapy Landscape Analysis by Major End-Users

    8 Middle West USA Cancer Immunotherapy Landscape Analysis

    • 8.1 Middle West USA Cancer Immunotherapy Landscape Analysis by Major Types

    • 8.2 Middle West USA Cancer Immunotherapy Landscape Analysis by Major End-Users

    9 Northeast USA Cancer Immunotherapy Landscape Analysis

    • 9.1 Northeast USA Cancer Immunotherapy Landscape Analysis by Major Types

    • 9.2 Northeast USA Cancer Immunotherapy Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Novartis International Ag

        • 10.1.1 Novartis International Ag Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Pfizer Inc

        • 10.2.1 Pfizer Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Amgen Inc

        • 10.3.1 Amgen Inc Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Bristol-Myers Squibb

        • 10.4.1 Bristol-Myers Squibb Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Printegra

        • 10.5.1 Printegra Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Celgene Corporation

        • 10.6.1 Celgene Corporation Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 LLC

        • 10.7.1 LLC Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Janssen Global Services

        • 10.8.1 Janssen Global Services Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Seattle Genetics Inc

        • 10.9.1 Seattle Genetics Inc Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Merck & Co Inc

        • 10.10.1 Merck & Co Inc Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Gristone Oncology, Inc

        • 10.11.1 Gristone Oncology, Inc Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Immune System Modulators from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Cancer Vaccines from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Lung Cancer from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Breast Cancer from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Colorectal Cancer from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Melanoma from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Prostate Cancer from 2016 to 2027

    • Figure USA Cancer Immunotherapy Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Cancer Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Cancer Immunotherapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Cancer Immunotherapy

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer Immunotherapy by Different Types from 2016 to 2027

    • Table Consumption Share of Cancer Immunotherapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Immune Checkpoint Inhibitors

    • Figure Market Size and Growth Rate of Immune System Modulators

    • Figure Market Size and Growth Rate of Cancer Vaccines

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Cancer Immunotherapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Cancer Immunotherapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Lung Cancer

    • Figure Market Size and Growth Rate of Breast Cancer

    • Figure Market Size and Growth Rate of Colorectal Cancer

    • Figure Market Size and Growth Rate of Melanoma

    • Figure Market Size and Growth Rate of Prostate Cancer

    • Figure Market Size and Growth Rate of Others

    • Table USA Cancer Immunotherapy Production by Regions

    • Table USA Cancer Immunotherapy Production Share by Regions

    • Figure USA Cancer Immunotherapy Production Share by Regions in 2016

    • Figure USA Cancer Immunotherapy Production Share by Regions in 2021

    • Figure USA Cancer Immunotherapy Production Share by Regions in 2027

    • Table USA Cancer Immunotherapy Consumption by Regions

    • Table USA Cancer Immunotherapy Consumption Share by Regions

    • Figure USA Cancer Immunotherapy Consumption Share by Regions in 2016

    • Figure USA Cancer Immunotherapy Consumption Share by Regions in 2021

    • Figure USA Cancer Immunotherapy Consumption Share by Regions in 2027

    • Table West USA Cancer Immunotherapy Consumption by Types from 2016 to 2027

    • Table West USA Cancer Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure West USA Cancer Immunotherapy Consumption Share by Types in 2016

    • Figure West USA Cancer Immunotherapy Consumption Share by Types in 2021

    • Figure West USA Cancer Immunotherapy Consumption Share by Types in 2027

    • Table West USA Cancer Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table West USA Cancer Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Cancer Immunotherapy Consumption Share by End-Users in 2016

    • Figure West USA Cancer Immunotherapy Consumption Share by End-Users in 2021

    • Figure West USA Cancer Immunotherapy Consumption Share by End-Users in 2027

    • Table South USA Cancer Immunotherapy Consumption by Types from 2016 to 2027

    • Table South USA Cancer Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure South USA Cancer Immunotherapy Consumption Share by Types in 2016

    • Figure South USA Cancer Immunotherapy Consumption Share by Types in 2021

    • Figure South USA Cancer Immunotherapy Consumption Share by Types in 2027

    • Table South USA Cancer Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table South USA Cancer Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Cancer Immunotherapy Consumption Share by End-Users in 2016

    • Figure South USA Cancer Immunotherapy Consumption Share by End-Users in 2021

    • Figure South USA Cancer Immunotherapy Consumption Share by End-Users in 2027

    • Table Middle West USA Cancer Immunotherapy Consumption by Types from 2016 to 2027

    • Table Middle West USA Cancer Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Cancer Immunotherapy Consumption Share by Types in 2016

    • Figure Middle West USA Cancer Immunotherapy Consumption Share by Types in 2021

    • Figure Middle West USA Cancer Immunotherapy Consumption Share by Types in 2027

    • Table Middle West USA Cancer Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Cancer Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Cancer Immunotherapy Consumption Share by End-Users in 2016

    • Figure Middle West USA Cancer Immunotherapy Consumption Share by End-Users in 2021

    • Figure Middle West USA Cancer Immunotherapy Consumption Share by End-Users in 2027

    • Table Northeast USA Cancer Immunotherapy Consumption by Types from 2016 to 2027

    • Table Northeast USA Cancer Immunotherapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Cancer Immunotherapy Consumption Share by Types in 2016

    • Figure Northeast USA Cancer Immunotherapy Consumption Share by Types in 2021

    • Figure Northeast USA Cancer Immunotherapy Consumption Share by Types in 2027

    • Table Northeast USA Cancer Immunotherapy Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Cancer Immunotherapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Cancer Immunotherapy Consumption Share by End-Users in 2016

    • Figure Northeast USA Cancer Immunotherapy Consumption Share by End-Users in 2021

    • Figure Northeast USA Cancer Immunotherapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Novartis International Ag

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis International Ag

    • Figure Sales and Growth Rate Analysis of Novartis International Ag

    • Figure Revenue and Market Share Analysis of Novartis International Ag

    • Table Product and Service Introduction of Novartis International Ag

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Amgen Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

    • Figure Sales and Growth Rate Analysis of Amgen Inc

    • Figure Revenue and Market Share Analysis of Amgen Inc

    • Table Product and Service Introduction of Amgen Inc

    • Table Company Profile and Development Status of Bristol-Myers Squibb

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb

    • Table Product and Service Introduction of Bristol-Myers Squibb

    • Table Company Profile and Development Status of Printegra

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Printegra

    • Figure Sales and Growth Rate Analysis of Printegra

    • Figure Revenue and Market Share Analysis of Printegra

    • Table Product and Service Introduction of Printegra

    • Table Company Profile and Development Status of Celgene Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation

    • Figure Sales and Growth Rate Analysis of Celgene Corporation

    • Figure Revenue and Market Share Analysis of Celgene Corporation

    • Table Product and Service Introduction of Celgene Corporation

    • Table Company Profile and Development Status of LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LLC

    • Figure Sales and Growth Rate Analysis of LLC

    • Figure Revenue and Market Share Analysis of LLC

    • Table Product and Service Introduction of LLC

    • Table Company Profile and Development Status of Janssen Global Services

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen Global Services

    • Figure Sales and Growth Rate Analysis of Janssen Global Services

    • Figure Revenue and Market Share Analysis of Janssen Global Services

    • Table Product and Service Introduction of Janssen Global Services

    • Table Company Profile and Development Status of Seattle Genetics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics Inc

    • Figure Sales and Growth Rate Analysis of Seattle Genetics Inc

    • Figure Revenue and Market Share Analysis of Seattle Genetics Inc

    • Table Product and Service Introduction of Seattle Genetics Inc

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of Gristone Oncology, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gristone Oncology, Inc

    • Figure Sales and Growth Rate Analysis of Gristone Oncology, Inc

    • Figure Revenue and Market Share Analysis of Gristone Oncology, Inc

    • Table Product and Service Introduction of Gristone Oncology, Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.